B-cell depletion with unconjugated CD20 monoclonal antibody (mAb) is used to treat rheumatoid arthritis and other autoimmune diseases. CD20-targeted immunotherapy depletes mature B cells through ...

Although sustained remission free of disease-modifying antirheumatic drugs “does not seem attainable” for patients with ...

Women with an age at first birth (AFB) younger than 26 or older than 35 years have a higher risk for developing rheumatoid ...